Abstract:Abstract It is tough to detect unexpected drug–drug interactions (DDIs) in poly-drug treatments because of high costs and clinical limitations. Computational approaches, such as deep learning-based approaches, are promising to screen potential DDIs among numerous drug pairs. Nevertheless, existing approaches neglect the asymmetric roles of two drugs in interaction. Such an asymmetry is crucial to poly-drug treatments since it determines drug priority in co-prescription. This paper designs a directed graph attention network (DGAT-DDI) to predict asymmetric DDIs. First, its encoder learns the embeddings of the source role, the target role and the self-roles of a drug. The source role embedding represents how a drug influences other drugs in DDIs. In contrast, the target role embedding represents how it is influenced by others. The self-role embedding encodes its chemical structure in a role-specific manner. Besides, two role-specific items, aggressiveness and impressionability, capture how the number of interaction partners of a drug affects its interaction tendency. Furthermore, the predictor of DGAT-DDI discriminates direction-specific interactions by the combination between two proximities and the above two role-specific items. The proximities measure the similarity between source/target embeddings and self-role embeddings. In the designated experiments, the comparison with state-of-the-art deep learning models demonstrates the superiority of DGAT-DDI across a direction-specific predicting task and a direction-blinded predicting task. An ablation study reveals how well each component of DGAT-DDI contributes to its ability. Moreover, a case study of finding novel DDIs confirms its practical ability, where 7 out of the top 10 candidates are validated in DrugBank.

GCN-BMP: Investigating graph representation learning for DDI prediction task

Drug-drug Interaction Prediction with Graph Representation Learning

RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction

Predicting drug–drug interactions by graph convolutional network with multi-kernel

Hierarchical Multi-Relational Graph Representation Learning for Large-Scale Prediction of Drug-Drug Interactions

Benchmarking Graph Learning for Drug-Drug Interaction Prediction

Multi-Relational Contrastive Learning Graph Neural Network for Drug-Drug Interaction Event Prediction

Knowledge Graph Neural Network with Spatial-Aware Capsule for Drug-Drug Interaction Prediction

Graph-augmented Convolutional Networks on Drug-Drug Interactions Prediction

Attention-based Knowledge Graph Representation Learning for Predicting Drug-drug Interactions

MASMDDI: multi-layer adaptive soft-mask graph neural network for drug-drug interaction prediction

MRGCDDI: Multi-Relation Graph Contrastive Learning without Data Augmentation for Drug-Drug Interaction Events Prediction

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs

Directed graph attention networks for predicting asymmetric drug–drug interactions

A knowledge graph-based method for drug-drug interaction prediction with contrastive learning

CADGL: Context-Aware Deep Graph Learning for Predicting Drug-Drug Interactions

Positive Sample Augmentation with Graph Mixup for DDI Prediction

MGDDI: A multi-scale graph neural networks for drug-drug interaction prediction

3DGT-DDI: 3D graph and text based neural network for drug-drug interaction prediction

AutoDDI: Drug–Drug Interaction Prediction With Automated Graph Neural Network

BiRNN-DDI: A Drug-Drug Interaction Event Type Prediction Model Based on Bidirectional Recurrent Neural Network and Graph2Seq Representation